Mentioned Users

MyMSTeam

GLP-1 receptor agonists (like Ozempic/semaglutide and Wegovy) appear to be generally safe and well-tolerated for people with MS, based on early research. A small study of 33 people with MS taking GLP-1 drugs found no relapses during the study period, though some participants did show new lesions on MRI scans. About 1 in 4 Show Full Answer

GLP-1 receptor agonists (like Ozempic/semaglutide and Wegovy) appear to be generally safe and well-tolerated for people with MS, based on early research. A small study of 33 people with MS taking GLP-1 drugs found no relapses during the study period, though some participants did show new lesions on MRI scans. About 1 in 4 participants in that study reported gastrointestinal side effects, including:

- Stomach pain
- Nausea
- Vomiting

Only one person stopped taking the medication due to side effects. There's also some exciting early-stage research suggesting GLP-1 agonists might help protect or even repair myelin (the nerve sheath damaged in MS). However, no clinical trials have tested this yet, so more research is needed before drawing firm conclusions. Neurologist Dr. Aaron Boster advises that if weight loss is a goal, GLP-1 agonists can be a helpful tool — but not a standalone solution. He recommends pairing them with exercise and healthy eating habits. He also cautions against yo-yo weight cycling, as repeatedly losing and regaining weight can have its own health consequences.

As always, it's best to discuss this with your MS care team to see if it's the right fit for your specific situation.

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

Ozempic and Multiple Sclerosis: Insights From Dr. Aaron Boster on GLP-1 Agonists

Can MS Cause Weight Change? 4 Tips for Maintaining a Healthy Weight